SCHEMBL25948667

SCHEMBL25948667

Cc1nc2c(Cc3ccccc3)ncnc2n1C1CCCCO1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 1/20 0.47
▸ RAB9A P51151 1/20 0.47
▸ SMN1; SMN2 Q16637 1/20 0.47
▸ CYP2C19 P33261 1/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ TSHR P16473 1/20 0.39
▸ PDE8B O95263 1/20 0.37
▸ PDE10A Q9Y233 1/20 0.37
▸ ADORA3 P0DMS8 6/20 0.36
▸ ADORA2A P29274 6/20 0.36
▸ ADORA2B P29275 6/20 0.36
▸ ADORA1 P30542 6/20 0.36
▸ ALDH1A1 P00352 2/20 0.35
▸ YTHDC1 Q96MU7 1/20 0.35
▸ TP53 P04637 1/20 0.34
▸ CYP2C9 P11712 1/20 0.34
▸ NFKB1 P19838 1/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ HSD17B10 Q99714 1/20 0.34
▸ MEN1 O00255 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21685477 0.85 NPC1 (0.46) NPC1RAB9ASMN1; SMN2CYP2C19CYP1A2
SCHEMBL21684878 0.81 NPC1 (0.41) NPC1RAB9ASMN1; SMN2CYP2C19CYP1A2
SCHEMBL21685038 0.81 NPC1 (0.41) NPC1RAB9ASMN1; SMN2CYP2C19CYP1A2
SCHEMBL28578067 0.80 NPC1 (0.40) NPC1RAB9ASMN1; SMN2CYP2C19CYP1A2
SCHEMBL27920376 0.79 NPC1 (0.69) NPC1RAB9ASMN1; SMN2CYP2C19CYP1A2
SCHEMBL21703448 0.79 MAP4K1 (0.43) NPC1RAB9ASMN1; SMN2CYP2C19CYP1A2
SCHEMBL21684666 0.79 NPC1 (0.42) NPC1RAB9ASMN1; SMN2CYP2C19CYP1A2
SCHEMBL21703018 0.78 MAP4K1 (0.51) NPC1RAB9ASMN1; SMN2CYP2C19CYP1A2
SCHEMBL21684983 0.77 MAP4K1 (0.46) NPC1RAB9ASMN1; SMN2CYP1A2TSHR
SCHEMBL14964663 0.77 CYP2C19 (0.45) NPC1RAB9ASMN1; SMN2CYP2C19CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4219460-A1 TRANSGLUTAMINASE 2 (TG2) INHIBITORS Sitari Pharma, Inc. (US) 2023-08-02 — — EP disclosed
Send feedback